Rakuten Medical Competitors and Similar CompaniesClear all
Rakuten Medical's competitors and similar companies include Halozyme Therapeutics, Forbius, Kiromic Biopharma and BlinkBio.
 Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. |  Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | ||
Founding Date | Founding Date 2013 | Founding Date 1998 | Founding Date 2011 | Founding Date 2012 | Founding Date 2009 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US | Locations San Diego, US HQ | Locations Austin, US HQ Montréal, CA | Locations Houston, US HQ | Locations Jupiter, US HQ |
Employees | Employees 1241% increase | Employees 373157% increase | Employees 811% decrease | Employees 4426% increase | Employees 5 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.4 b | Valuation ($) N/A | Valuation ($) 1.8 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income $316.9m (FY, 2025) | Net income N/A | Net income ($26.9m) (FY, 2024) | Net income N/A |
Operating ⚠ | |||||
Preclinical Phase Products | Preclinical Phase Products N/A | Preclinical Phase Products 2 (FY, 2018) | Preclinical Phase Products N/A | Preclinical Phase Products 2 (Q2, 2020) | Preclinical Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 451.9m | Total funding raised $ 171.9m | Total funding raised N/A | Total funding raised $ 135k | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyForbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companyKiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
BlinkBio
HQ
Jupiter, US
Employees
5
BlinkBio is a company developing tunable drug conjugates (TDCs) therapies.
View company